Immunome terminates Deloitte as auditor, appoints Ernst & Young effective Oct 4, 2022

Immunome Inc.

Audit committee terminated Deloitte on Sept 30, 2022; appointed EY effective Oct 4, 2022.
Deloitte's audits for FY 2021 and 2020 contained no adverse opinion or qualification.
No disagreements on accounting principles or reportable events during FY 2021-2022 interim periods.
No prior consultations with EY regarding accounting principles or audit opinions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.